STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4065 by analyst upside · 2026-06-27
AMN
AMN Healthcare Services, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
-14.1%
implied upside to consensus target
Current Price $32.76
Consensus Target $28.14
Bull Target $36.0
Bear Target $22.0
Analysts Covering 7
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
2
Hold
4
Sell
0
52-Week Low $14.87
52-Week High $33.48
YTD Return +116.7%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E 30.2x
EPS (TTM) $-0.86
PEG Ratio 1.22
Dividend Yield N/A
Revenue (TTM) $3.4B
Profit Margin -0.9%
52-WEEK RANGE
52-Week Low $14.87
52-Week High $33.48
Current Price $32.76
Bear Target $22.0
Bull Target $36.0
● Now $32.76 ● Target $28.14
TRADING DATA
Avg Volume 1.0M
YTD Return +116.7%
Analyst Count 7
Consensus Buy
Upside to Target -14.1%
Last Updated 2026-06-27

ANALYST SUMMARY

AMN Healthcare Services, Inc. (AMN) is currently trading at $32.76 with a Wall Street consensus price target of $28.14, which is 14.1% below the current price over the next 12 months. 7 analysts currently cover AMN, with a consensus rating of Buy — 43% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $36.0, while the most cautious has a target of $22.0.

AMN operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 116.7% year-to-date and is currently trading near the upper end of its 52-week range of $14.87 – $33.48.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for AMN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS — Reiterated
Neutral → Neutral 2026-05-13 33% win rate (6 calls)
BMO Capital — Reiterated
Outperform → Outperform 2026-05-11 Building track record
Baird — Reiterated
Neutral → Neutral 2026-05-11 Building track record
Truist Securities — Reiterated
Buy → Buy 2026-05-08 Building track record
Citizens — Reiterated
Market Outperform → Market Outperform 2026-02-23 Building track record
Baird — Reiterated
Neutral → Neutral 2026-02-20 Building track record
UBS — Reiterated
Neutral → Neutral 2026-02-20 33% win rate (6 calls)
BMO Capital — Reiterated
Outperform → Outperform 2026-01-15 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →